highperformr logo

Aavis Pharmaceuticals's Overview

Total employees53
HeadquartersPiscataway
Founded2015

Aavis Pharmaceuticals is a dynamic and rapidly expanding specialty pharmaceutical company. It focuses on the development, manufacturing, marketing, and distribution of both generic and branded pharmaceutical products. Key therapeutic areas for Aavis include Central Nervous System (CNS) disorders, Cardiovascular (CVS) conditions, anti-infectives, anti-inflammatories, and analgesics. The company is committed to providing high-quality, affordable medicines and innovative drug delivery solutions to improve patient outcomes.

Where is Aavis Pharmaceuticals's Headquarters?

HQ Function

Serves as the corporate headquarters for Aavis Pharmaceuticals, overseeing strategic direction, business development, marketing, distribution, and administrative functions for its U.S. and global operations.

Notable Features:

Located in a modern corporate park in New Jersey's pharmaceutical hub, providing access to advanced office facilities. Specific architectural details are not publicly highlighted, but the environment supports collaborative and efficient business operations.

Work Culture:

Aavis Pharmaceuticals fosters a culture centered on growth, innovation, quality, and integrity. The environment is likely dynamic and results-oriented, encouraging collaboration to expand the company's product portfolio and market presence in the pharmaceutical sector.

HQ Significance:

The Piscataway headquarters is strategically positioned within New Jersey's prominent pharmaceutical corridor. This location offers Aavis access to a rich talent pool, extensive industry networks, and proximity to key U.S. markets, serving as the central hub for decision-making and global strategy.

Values Reflected in HQ: The choice of a modern, professional setting for its headquarters reflects Aavis's commitment to operational excellence, strategic growth, and maintaining a strong presence within the competitive pharmaceutical industry.

Location:

Aavis Pharmaceuticals operates with a global perspective, maintaining key facilities in the United States (New Jersey and Delaware) and an important operational hub in India (Hyderabad). The company's global functions include research and development collaborations, end-to-end product development, strategic manufacturing partnerships, international regulatory affairs, and the marketing and distribution of its diverse portfolio of pharmaceutical products across various international markets.

Street Address:

15 Corporate Place South, Suite # 420

City:

Piscataway

State/Province:

New Jersey

Country:

USA

Aavis Pharmaceuticals's Global Presence

Newark, Delaware, USA

Address: 200 Continental Drive, Suite # 401, Newark, DE 19713, USA

Strategically located to leverage Delaware's growing biotech ecosystem and access scientific talent, this R&D center is crucial for Aavis's innovation and development of both generic and specialty pharmaceuticals.

Hyderabad, Telangana, India

Address: Specific street address not publicly listed, general location: Hyderabad

This office enables Aavis to tap into India's significant pharmaceutical talent pool, manage international supply chains, and expand its market access and operational footprint in the strategically important Asia-Pacific region.

Buying Intent Signals for Aavis Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Aavis Pharmaceuticals

As of April 2025, Aavis Pharmaceuticals' leadership includes:

Vimal Kavuru - Chairman & CEO
Ashok Kumar - President
Suresh Ketha - Senior Vice President, Portfolio and Business Development
Nitin Brahmbhatt - Vice President, Business Development and M&A
Ranjit Barshikar - Head of Quality and Regulatory Affairs

Investors of Aavis Pharmaceuticals

Aavis Pharmaceuticals has been backed by several prominent investors over the years, including:

Aavis Pharmaceuticals is a privately held company. Detailed information about specific external investors beyond the founding leadership is not publicly disclosed. The company's growth is supported by its operational revenues and strategic financial management.

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

Based on publicly available information, there have been no major announcements regarding executive hires or departures at Aavis Pharmaceuticals within the last 12 months. The current leadership team appears to be stable.

Technology (Tech Stack) used by Aavis Pharmaceuticals

Discover the tools Aavis Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Aavis Pharmaceuticals Email Formats and Examples

The common email formats for Aavis Pharmaceuticals are predicted based on standard industry patterns for companies with the domain 'aavispharma.com'. These are not officially confirmed and variations may exist.

[first_initial][last]@aavispharma.com (e.g., jdoe@aavispharma.com) or [first].[last]@aavispharma.com (e.g., jane.doe@aavispharma.com)

Format

vkavuru@aavispharma.com (example, based on a common pattern for executives)

Example

70%

Success rate

News and media

Aavis Pharmaceuticals Official WebsiteNovember 21, 2023

Aavis Pharmaceuticals Acquires Burel Pharmaceutical, Inc.

Aavis Pharmaceuticals announced its strategic acquisition of Burel Pharmaceutical, Inc. This move is set to expand Aavis's product portfolio and strengthen its market presence in various therapeutic categories....more

Aavis Pharmaceuticals Official WebsiteNovember 14, 2023

Aavis Pharmaceuticals Launches Three New Products

Reinforcing its commitment to growth and patient care, Aavis Pharmaceuticals announced the successful launch of three new pharmaceutical products, further diversifying its offerings in key therapeutic areas....more

GlobeNewswireOctober 10, 2023

Assertio Announces Agreement to Divest Select Products to Aavis Pharmaceuticals

Aavis Pharmaceuticals entered into an agreement with Assertio Holdings, Inc. to acquire seven approved Abbreviated New Drug Applications (ANDAs) and one pending ANDA. This acquisition significantly bolsters Aavis's generic product pipeline....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Aavis Pharmaceuticals, are just a search away.